Michael Gelband’s Ocugen OCGN Stock Holding History

Michael Gelband’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,365	Closed	-$47.7K	–	1923
2026 Q1	$47.7K	Sell	26,365 -88,614	-77%	-$153K	﹤0.01%	1460
2025 Q4	$155K	Buy	+114,979	New	+$164K	﹤0.01%	1409
2025 Q3	–	Sell	-30,824	Closed	-$30K	–	1877
2025 Q2	$30K	Buy	+30,824	New	+$25.6K	﹤0.01%	1379
2024 Q4	–	Sell	-37,981	Closed	-$38K	–	1898
2024 Q3	$38K	Buy	+37,981	New	+$52.1K	﹤0.01%	1550
2023 Q2	–	Sell	-209,442	Closed	-$179K	–	2137
2023 Q1	$179K	Buy	+209,442	New	+$228K	﹤0.01%	1587
2022 Q4	–	Sell	-45,521	Closed	-$81K	–	1981
2022 Q3	$81K	Buy	+45,521	New	+$113K	﹤0.01%	1764
2022 Q1	–	Sell	-22,263	Closed	-$101K	–	2541
2021 Q4	$101K	Buy	+22,263	New	+$168K	﹤0.01%	1948
2020 Q1	–	Sell	-22,300	Closed	-$12K	–	1482
2019 Q4	$12K	Buy	+22,300	New	+$22.2K	﹤0.01%	1471

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Michael Gelband's OCGN Position: Q2 2026 in Review

Michael Gelband sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 26,365 shares — an estimated $47.7K sold.

Michael Gelband first reported a position in OCGN in Q4 2019 and held it in 8 quarters. The position peaked at $179K in Q1 2023. 146 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Michael Gelband reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 26,365 Ocugen shares in Q2 2026, an estimated $47.7K.
Michael Gelband first reported a position in Ocugen in Q4 2019 and held it in 8 quarters.
Michael Gelband's Ocugen position peaked at $179K in Q1 2023.
146 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.